Study uncovers consequences of molnupiravir use to treat COVID-19
A collaboration between the University of Tasmania and Royal Hobart Hospital Pathology has revealed the consequences of using molnupiravir to treat COVID-19.
Apr 8, 2024
0
45
A collaboration between the University of Tasmania and Royal Hobart Hospital Pathology has revealed the consequences of using molnupiravir to treat COVID-19.
Apr 8, 2024
0
45
The human cytomegalovirus, HCMV for short, lies dormant unnoticed in the body of most people for their entire lives. In immunocompromised individuals, however, the virus can cause life-threatening infections. It infects dendritic ...
Feb 27, 2024
0
21
In the first comprehensive evidence-based guideline on the use of fecal microbiota-based therapies for gastrointestinal disease, the American Gastroenterological Association recommends fecal microbiota transplant (FMT) for ...
Feb 21, 2024
0
0
Common symptoms of liver inflammation caused by hepatitis E viruses (HEV) include fever, abdominal pain, pale stools, nausea, and jaundice. Individuals at risk for this infection include persons with weakened immune systems ...
Feb 16, 2024
0
0
First-year Hackensack Meridian School of Medicine (HMSOM) student Elizabeth Titova leveraged her background in phlebotomy and scientific research to publish a new clinical study around COVID-19 vaccination in Microbiology ...
Feb 15, 2024
0
33
A life-threatening mold infection known as health care-associated Fusarium solani meningitis can be associated with a delayed, but devastating, injury to the brainstem and its blood supply among those infected, according ...
Feb 8, 2024
0
1
Early in the pandemic, clinicians noticed that certain immunocompromised patients were experiencing persistent SARS-CoV-2 infections, some lasting weeks to months at a time.
Jan 26, 2024
1
20
Individuals who are immunocompromised are at risk of worse COVID-19 outcomes and may have a less robust response to vaccination compared to non-immunocompromised individuals. But the term "immunocompromised" refers to a wide ...
Jan 24, 2024
0
9
Despite the end of the pandemic, COVID-19 continues to pose a serious health threat. Most individuals have established robust immune protection and do not develop severe disease but the infection can still lead to marked ...
Jan 9, 2024
0
119
Scientists studied the role of global genetic characterization of samples (or non-targeted metagenomics) using next-generation sequencing (mNGS) in diagnosing infections. The results of the study are published in the journal ...
Dec 18, 2023
0
0